TetraSOD®, a Unique Marine Microalgae Ingredient, Promotes an Antioxidant and Anti-Inflammatory Status in a Metabolic Syndrome-Induced Model in Rats

Increased oxidative stress has been linked to the pathogenic process of obesity and can trigger inflammation, which is often linked with the risk factors that make up metabolic syndrome (MetS), including obesity, insulin resistance, dyslipidaemia and hypertension. TetraSOD (R), a natural marine vegan ingredient derived from the microalgae Tetraselmis chuii that is high in the antioxidant enzymes superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) has recently demonstrated in vitro increased activity of these key antioxidant enzymes. In the present study, the potential bioactive effects of three dietary dosages of TetraSOD (R) in enhancing antioxidant and anti-inflammatory mechanisms to combat the metabolic disturbances that compose MetS were assessed in rats given a cafeteria (CAF) diet. Chronic supplementation with 0.17, 1.7, and 17 mg kg(-1) day(-1) of TetraSOD (R) for 8 weeks ameliorated the abnormalities associated with MetS, including oxidative stress and inflammation, promoting endogenous antioxidant defence mechanisms in the liver (GPx and GSH), modulating oxidative stress and inflammatory markers in plasma (NOx, oxLDL and IL-10), and regulating genes involved in antioxidant, anti-inflammatory and immunomodulatory pathways in the liver, mesenteric white adipose tissue (MWAT), thymus, and spleen. Overall, TetraSOD (R) appears to be a potential therapeutic option for the management of MetS.

Automated summary

TetraSOD (R), derived from the microalgae Tetraselmis chuii, is high in antioxidant enzymes and has the potential to enhance antioxidant and anti-inflammatory mechanisms to combat metabolic disturbances associated with Metabolic Syndrome (MetS). Research has shown that chronic supplementation with TetraSOD (R) can ameliorate abnormalities associated with MetS, including oxidative stress and inflammation, by promoting endogenous antioxidant defence mechanisms and regulating genes involved in antioxidant, anti-inflammatory, and immunomodulatory pathways in various tissues. Overall, TetraSOD (R) appears to be a promising therapeutic option for managing MetS.